Latest KFF Health News Stories
Podcast: KHN’s ‘What The Health?’ What’s Next For The FDA?
Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss the resignation of Food and Drug Administration Commissioner Scott Gottlieb, the latest on federal and state efforts to shore up the Affordable Care Act; and how public health officials plan to persuade parents who are reluctant to vaccinate their kids. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week.
Hidden FDA Reports Detail Harm Caused By Scores Of Medical Devices
The Food and Drug Administration has let medical device companies file reports of injuries and malfunctions outside a widely scrutinized public database, leaving doctors and medical sleuths in the dark.
A Mumps Quarantine In La. May Encroach On Rights Of Detained Immigrants
A recent outbreak at a Louisiana center triggered public health protections, but some immigration lawyers are crying foul.
Cities And Counties Unlikely To Heed FDA Warning On Importing Foreign Drugs
The Food and Drug Administration claims CanaRX, a company used by more than 500 cities, counties and school districts to help their employees get cheaper drugs from overseas, has sent “unapproved” and “misbranded” drugs to U.S. consumers, jeopardizing their safety.
California Looks To Lead Nation In Unraveling Childhood Trauma
The Golden State, in a movement spearheaded by its first-ever surgeon general, stands to become a vanguard for the nation in tracing adverse childhood experiences, or ACEs, to the onset of physical and mental illness. But what can a pediatrician, with her 15-minute time slots and extensive to-do list, do about the ills of an absent parent or a neighborhood riddled with gun violence?
Patients Question How FDA Approves Medical Devices
High-profile failures of implantable medical devices — such as certain hip joints and pelvic mesh — have prompted the Food and Drug Administration to revise its assessment process.
This Time When My Water Breaks, Take Me To A Hospital Without Surprise Bills
New research shows how an experience with surprise medical bills can guide patients’ future decision-making.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Medicare Trims Payments To 800 Hospitals, Citing Patient Safety Incidents
The penalties are part of a program set up by the Affordable Care Act to prompt hospitals to pay more attention to safety issues that can lead to injuries, such as falls or hospital-acquired infections.
Americans Ready To Crack Down On Drug Prices That Force Some To Skip Doses
In a new poll, consumers give thumbs up to ads that display drug prices and the removal of barriers to generics, among other cost-cutting measures.
Podcast: KHN’s ‘What The Health?’ ‘Medicare-For-All’ Debate: Who’s Going To Pay
Margot Sanger-Katz of The New York Times, Paige Winfield Cunningham of The Washington Post and Jennifer Haberkorn of the Los Angeles Times join KHN’s Julie Rovner to discuss the new “Medicare-for-all” bill introduced by House Democrats, the grilling of pharmaceutical company CEOs by a Senate committee and new Trump administration rules that take aim at Planned Parenthood. Plus, Rovner interviews KHN’s Julie Appleby about the latest “Bill of the Month” installment.
Listening To Older Patients Who Want To Stop Dialysis
Older adults with advanced kidney disease sometimes want to stop dialysis but often meet resistance from doctors, new research shows. We explore options available to these patients, including conservative care.
Despite 1991 Ruling, Foes Of New Family Planning Rules See Law On Their Side
Lawyers seeking to block the Trump administration’s decision to alter rules for the Title X family planning program say their efforts will not be stymied by the Supreme Court’s approval of similar rules 28 years ago. They point to new protections enacted in the Affordable Care Act and language in funding bills that shifts the legal calculus.
Detention Centers In California Lack Oversight And Proper Care, Reports Find
Health and safety problems at immigration detention facilities throughout California pose a serious risk to detainees, according to two reports released Tuesday. State Attorney General Xavier Becerra and California State Auditor Elaine Howle concluded that federal and local governments are failing to adequately oversee the facilities, allowing the problems to persist.
Pharma Execs Dig In For A Fight Against Outraged Senators
The Senate Finance Committee grilled executives from seven major drugmakers on Tuesday.
In Florida, Drug Importation From Canada Finds New Champions, Old Snags
The state’s governor said the plan has the full support of the White House. But the Trump administration was noncommittal about whether allowing states to buy and import cheaper drugs from up north could be the answer to the nation’s drug-pricing problem.
A Parent-To-Parent Campaign To Get Vaccine Rates Up
Kim Nelson started the group South Carolina Parents for Vaccines after learning that religious exemptions from vaccine requirements were way up in her community.
HHS Finalizes Rule Seeking To Expel Planned Parenthood From Family Planning Program
The new regulation would drop previous rules for the Title X program requiring that women with unintended pregnancies be told about all options, including abortion. It would also mandate that organizations separate facilities providing federally funded services from those providing abortions.
Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
Tuesday’s Senate hearing with pharma CEOs will tackle the same issues as the famous Kefauver hearings in 1960.
Today’s Concerns About Drug Prices Echo The Past
Confrontational hearings 60 years ago sparked remarkably similar quotes about drug prices and health care policy.
